Peter's research focuses on developing computational and statistical methods for single‑cell genomics to uncover cellular heterogeneity and regulatory mechanisms in development, immunity, and disease. His work spans algorithm design, integrative analysis of large‑scale single‑cell data, and translational applications in precision medicine.

He has authored numerous highly cited publications that have shaped the field of single‑cell analysis and computational genomics. Since his time in Harvard Medical School and Altos Labs, his lab continues to advance methods that enable deeper insight into complex biological systems and inform therapeutic discovery.

Peter is currently a visiting fellow at the Institute of Molecular Biotechnology in Vienna, Austria.

Fuchou leads the Single‑Cell Biology and Genetics Lab at the Beijing Advanced Innovation Center for Genomics at Peking University. A pioneer in single‑cell genomics, his work has advanced our understanding of mammalian development, stem cell biology, and reproductive biology through innovative methods including single‑cell sequencing and lineage tracing.

His research has contributed key insights into early embryonic development, gametogenesis, and cellular heterogeneity, and he has authored numerous high‑impact publications in the field. His work bridges fundamental biology and translational applications in human health.

Fuchou is currently a Professor at BIOPIC, College of Life Sciences, Peking University. He is also Associate Director of Beijing Advanced Innovation Center for Genomics (ICG).

Angela's interdisciplinary research bridges biology and engineering, focusing on single‑cell and multi‑omics technologies, microfluidics, and clinical genomics to understand disease mechanisms and enable new diagnostics. 

Her contributions to the field of single-cell analysis technologies, along with her work at Agenovir Corporation, earned her international recognition as one of MIT Technology Review’s Top 10 Innovators Under 35 in Asia in 2017. In 2018, she was honored as a World Economic Forum Young Scientist.

Angela is currently Associate Professor in the Division of Life Science and the Department of Chemical and Biological Engineering at The Hong Kong University of Science and Technology (HKUST). She serves as Associate Director of the Center for Epigenomics Research and is affiliated with the State Key Laboratory of Nervous System Disorders and the Center for Aging Science.

Chung is a Team Leader at RIKEN who aims to understand the origins and functions of non-coding transcription in human genome, with a focus on long non-coding RNAs and enhancer RNAs.

His lab has been at the forefront of annotating these non-coding RNAs using large-scale in-house transcriptomic datasets (e.g. FANTOM). They also integrate our in-house datasets with public epigenomic and genetic (e.g. GWAS and eQTL) datasets to gain insights into the roles of non-coding RNAs in human diseases.

Ruby is Professor at the School of Medicine, National Taiwan University, and Visiting Professor at the Department of Obstetrics and Gynaecology at the National University of Singapore.

A clinician-scientist trained in obstetrics and gynaecology, her research focuses on ovarian cancer biology, cancer genomics, and epithelial-mesenchymal transition (EMT). Her work has helped redefine EMT as a continuous spectrum and established widely used EMT gene-expression signatures to study tumor heterogeneity and therapeutic response. Her group applies genomics and spatial profiling approaches to understand ovarian cancer subtypes and advance precision oncology.

Hae‑Ock is a cancer researcher and immunologist with extensive experience in single‑cell transcriptomics and translational oncology.

She received her PhD in Immunology from Northwestern University in the USA and, in 2013, joined the Samsung Genome Institute where she applied single‑cell technologies to study diverse cancer types. In 2020, she moved to the Catholic University of Korea, where her research focuses on lung cancer, aiming to identify predictive biomarkers and novel therapeutic targets to improve precision oncology.

Ryan leads a research group investigating the epigenome and cell identity, at the University of Western Australia and the Harry Perkins Institute of Medical Research.

After receiving his PhD from UWA in 2005, he undertook postdoctoral studies at The Salk Institute for Biological Studies, where he developed and applied new techniques to map the epigenome and transcriptome. Having returned to UWA in 2012, his lab is focused on understanding the role of the epigenome in regulation of cell identity, and developing molecular tools to precisely edit the epigenome and transcriptional activity to control cell state and functions.

Partha is a National Science Chair of the Government of India, Distinguished Professor at the John C. Martin Centre for Liver Research & Innovations, and Emeritus Professor at the Indian Statistical Institute. He is also the founder of the National Institute of Biomedical Genomics in India.

He has developed novel statistical methodologies for mapping human disease genes, identified genomic factors underlying many diseases notably oral cancer, and has contributed  immensely to capacity-building in human and statistical genetics in India.

Thuong currently leads the TB group at OUCRU to improve TB diagnosis and treatment by carrying out clinical trials of new diagnostic tests and therapeutic approaches.

She currently holds a Wellcome International Intermediate Fellowship focused on linking human genotype and immunological phenotype to better understand TB pathogenesis using transcriptomics. 

Her group also seeks to understand more about how genetic variations in both host and pathogen influence disease presentations, treatment response and outcomes.

Anunya is a systems immunologist who combines bioinformatics and genomics to understand why infections and vaccines affect each person differently. As Principal Investigator at Mahidol University's Faculty of Dentistry, she uses single-cell transcriptomics and immunogenomics to decode the regulatory mechanisms underlying individual immune responses. Her work focuses on post-viral immune dysregulation, vaccinology and cross-compartment immunity.

Woong-Yang is Professor of Molecular Cell Biology at Sungkyunkwan University School of Medicine and Director of the Samsung Genome Institute at Samsung Medical Center in Seoul, South Korea. He is also the CEO of Geninus, where he leads the company’s vision to develop global AI-driven solutions for genome-based drug discovery and precision medicine. Widely recognized for his work in genome mapping and cancer genomics, his research focuses on single-cell technologies and translating genomic insights into improved diagnostics and therapies.

Sarah is co-founder and co-chair of HCA. She is currently Chair in Stem Cell Medicine at the University of Cambridge’s Stem Cell Institute and Department of Medicine.

A computational biologist and genomics pioneer, her research develops and applies single-cell and spatial genomics to understand human tissue organization, immune cell diversity, and disease.

Sarah is an EMBO member and a Fellow of the Academy of Medical Sciences and Royal Society, as well as a Fellow of the International Society of Computational Biology. Her work has been recognized by a number of prizes, including the Lister Prize, Biochemical Society Colworth Medal, Royal Society Crick Lecture and EMBO Gold Medal.

Casimiro is an expert in the Division of Science Policy and Capacity-Building at UNESCO, where he works at the intersection of science policy, international cooperation, and open science. Trained as a medical doctor at the University of Palermo, he later specialized in international cooperation at IRIS in Paris.

At UNESCO, he leads and contributes to global initiatives that strengthen scientific collaboration and capacity building, including projects such as PERFORM and partnerships supporting equitable access to genomics and open science, including collaboration with the Human Cell Atlas to promote inclusive and ethical global research.

Emily leads the Regulatory Systems Laboratory at the Victor Chang Cardiac Research Institute and is an Associate Professor at UNSW Sydney.

Her research focuses on decoding the non-coding human genome to understand gene regulation in development, aging, and disease. Combining computational genomics with experimental biology, her team investigates regulatory elements that control cell identity and contribute to human disease.

She is also a recipient of the Fenner Medal from the Australian Academy of Science.

Yun Xia is a Nanyang Assistant Professor and Provost’s Chair in Stem Cell Biology at the Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.

Her research focuses on developing human stem cell-based models to study kidney development and disease. Her laboratory uses direct differentiation and multicellular self-organization to generate kidney organoids that recapitulate the structure and function of the native organ, enabling disease modelling and drug discovery.

She received the Stem Cell Society Singapore Dr. Susan Lim Young Investigator Award in 2020 and joined the EMBO Global Investigator Network in 2021. Since 2022, she has served as an Associate Editor for Kidney International.

Jian Yang is a New Cornerstone Investigator and Zhen-Xing Endowed Professor of Statistical Genetics at the School of Life Sciences, Westlake University, China.

His research focuses on genomic variation and its links to complex traits. He was the 2012 recipient of the Centenary Institute Lawrence Creative Prize, in recognition of his contribution to solving the ‘missing heritability’ paradox. He was awarded the Australian Academy of Science Ruth Stephens Gani Medal for distinguished research in human genetics (2015), and the Prime Minister’s Prize for Sciences - Frank Fenner Prize for Life Scientist of the Year (2017).

Seyhan is a Group Leader at the Garvan Institute of Medical Research, where she leads the Precision Immunology Program.

Her research focuses on developing precision biomarkers to aid clinical decision-making. Seyhan's expertise spans biostatistics, genetics, epidemiology, and bioinformatics, and she has been recognized for her significant contributions to the fields of population genetics, single-cell genomics, computational biology, autoimmune diseases, and eye health.